Jonathan M Feldman1,2, Denise Serebrisky3, Sheena Starr1, Katerina Castaño1, Naomi Greenfield1, Gabriella Silverstein1, Natalie Fruchter1, Jennifer Mammen4, Colleen McGovern5, Kimberly Arcoleo4. 1. Ferkauf Graduate School of Psychology, Yeshiva University, Bronx, NY, USA. 2. Department of Pediatrics, Division of Academic General Pediatrics, Albert Einstein College of Medicine, Children's Hospital at Montefiore, Bronx, NY, USA. 3. Department of Pediatrics, Jacobi Medical Center, Bronx, NY, USA. 4. College of Nursing, The University of Rhode Island, Kingston, RI, USA. 5. School of Nursing, University of North Carolina at Greensboro, Greensboro, NC, USA.
Abstract
OBJECTIVES: Asthma control improved during the COVID-19 pandemic. This study examined objectively measured medication adherence, asthma morbidity and quality of life (QoL) outcomes in Black and Latinx children by month for January-June 2019 (pre-COVID) compared to January-June 2020 (including first peak of COVID). METHODS: Secondary analyses of 94 children with asthma (ages 10-17 years, 64% Latinx, 36% Black) and their caregivers assigned to the comparison group of a longitudinal RCT intervention trial. Outcomes included mean aggregate electronic adherence for controller medications, oral steroid bursts, acute healthcare utilization, caregiver asthma QoL, and the Asthma Control Test. Repeated measures analyses were conducted due to multiple observations. RESULTS: Adherence to controller medications declined 48% from 2019 to 2020 (LS Mean = 33.9% vs. 17.6%, p=.0004, f=.92) with levels reaching a low in May 2020. A reduction in steroid bursts was observed over the same timeframe, 1.29 vs. 0.61, p = 0.006, f=.63. Caregiver QoL increased from 2019 to 2020 on total score (5.18 vs. 5.85, p = 0.002, f=.72), activity limitations (5.04 vs. 5.95), and emotional functioning (5.26 vs. 5.80). Although not statistically significant, a clinically meaningful 62% reduction in acute healthcare visits (p = 0.15) was reported in 2020. Children reported better asthma control (OR = 1.47, 95% CI 1.24, 1.73, p < 0.0001) in 2020 versus 2019 driven by improvements from May to June 2020. CONCLUSIONS: Decreased asthma morbidity in minority children during COVID was coupled with decreased adherence to controller medications. This observed decrease in morbidity is not explained by improvements in adherence.
OBJECTIVES: Asthma control improved during the COVID-19 pandemic. This study examined objectively measured medication adherence, asthma morbidity and quality of life (QoL) outcomes in Black and Latinx children by month for January-June 2019 (pre-COVID) compared to January-June 2020 (including first peak of COVID). METHODS: Secondary analyses of 94 children with asthma (ages 10-17 years, 64% Latinx, 36% Black) and their caregivers assigned to the comparison group of a longitudinal RCT intervention trial. Outcomes included mean aggregate electronic adherence for controller medications, oral steroid bursts, acute healthcare utilization, caregiver asthma QoL, and the Asthma Control Test. Repeated measures analyses were conducted due to multiple observations. RESULTS: Adherence to controller medications declined 48% from 2019 to 2020 (LS Mean = 33.9% vs. 17.6%, p=.0004, f=.92) with levels reaching a low in May 2020. A reduction in steroid bursts was observed over the same timeframe, 1.29 vs. 0.61, p = 0.006, f=.63. Caregiver QoL increased from 2019 to 2020 on total score (5.18 vs. 5.85, p = 0.002, f=.72), activity limitations (5.04 vs. 5.95), and emotional functioning (5.26 vs. 5.80). Although not statistically significant, a clinically meaningful 62% reduction in acute healthcare visits (p = 0.15) was reported in 2020. Children reported better asthma control (OR = 1.47, 95% CI 1.24, 1.73, p < 0.0001) in 2020 versus 2019 driven by improvements from May to June 2020. CONCLUSIONS: Decreased asthma morbidity in minority children during COVID was coupled with decreased adherence to controller medications. This observed decrease in morbidity is not explained by improvements in adherence.
Entities:
Keywords:
Compliance; asthma control; disparities; healthcare utilization; quality of life
Authors: Levon H Utidjian; Alexander G Fiks; A Russell Localio; Lihai Song; Mark J Ramos; Ron Keren; Louis M Bell; Robert W Grundmeier Journal: J Asthma Date: 2017-02-25 Impact factor: 2.515
Authors: Hernando Torres-Zevallos; Alfredo G Guerreros; Juan C Bazo-Alvarez; German F Alvarado; Karinna Vazquez; Jonathan M Feldman; Thomas Ritz Journal: J Asthma Date: 2020-03-11 Impact factor: 2.515
Authors: Kimberly J Arcoleo; Colleen McGovern; Karenjot Kaur; Jill S Halterman; Jennifer Mammen; Hugh Crean; Deepa Rastogi; Jonathan M Feldman Journal: Ann Am Thorac Soc Date: 2019-06
Authors: Amiel A Dror; Netanel Eisenbach; Tal Marshak; Eli Layous; Asaf Zigron; Shaked Shivatzki; Nicole G Morozov; Shahar Taiber; Eran E Alon; Ohad Ronen; Eyal Zusman; Samer Srouji; Eyal Sela Journal: J Allergy Clin Immunol Pract Date: 2020-09-02
Authors: Nikolaos G Papadopoulos; Alexander G Mathioudakis; Adnan Custovic; Antoine Deschildre; Wanda Phipatanakul; Gary Wong; Paraskevi Xepapadaki; Rola Abou-Taam; Ioana Agache; Jose A Castro-Rodriguez; Zhimin Chen; Pierrick Cros; Jean-Christophe Dubus; Zeinab Awad El-Sayed; Rasha El-Owaidy; Wojciech Feleszko; Vincenzo Fierro; Alessandro Fiocchi; Luis Garcia-Marcos; Anne Goh; Elham M Hossny; Yunuen R Huerta Villalobos; Tuomas Jartti; Pascal Le Roux; Julia Levina; Aida Inés López García; Ángel Mazón Ramos; Mário Morais-Almeida; Clare Murray; Karthik Nagaraju; Major K Nagaraju; Elsy Maureen Navarrete Rodriguez; Leyla Namazova-Baranova; Antonio Nieto Garcia; Cesar Fireth Pozo Beltrán; Thanaporn Ratchataswan; Daniela Rivero Yeverino; Eréndira Rodríguez Zagal; Cyril E Schweitzer; Marleena Tulkki; Katarzyna Wasilczuk; Dan Xu Journal: Allergy Date: 2021-03-24 Impact factor: 14.710
Authors: Leanne Kaye; Benjamin Theye; Ian Smeenk; Rahul Gondalia; Meredith A Barrett; David A Stempel Journal: J Allergy Clin Immunol Pract Date: 2020-05-01